Clinical Trials Insight: 700054830

Trial Profile

Clinical Trials Insight: 700054830

Phase of Trial: Phase III

Latest Information Update: 24 Mar 2010

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary) ; Aluminium hydroxide
  • Indications Hepatitis B
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 24 Mar 2010 New trial record
    • 25 Feb 2010 Primary endpoint 'Seroprotection rate' has been met.
    • 25 Feb 2010 Results published in Vaccine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top